000			01340 a2200361 4500
005			20250514010130.0
264		0	_c20010920
008			200109s 0 0 eng d
022			_a1524-4571
024	7		_a10.1161/hh1701.096259 _2doi
040			_aNLM _beng _cNLM
100	1		_aIsner, J M
245	0	0	_aAssessment of risks associated with cardiovascular gene therapy in human subjects. _h[electronic resource]
260			_bCirculation research _cAug 2001
300			_a389-400 p. _bdigital
500			_aPublication Type: Journal Article; Research Support, Non-U.S. Gov't; Research Support, U.S. Gov't, P.H.S.; Review
650	0	4	_aCardiovascular Diseases _xgenetics
650	0	4	_aClinical Trials as Topic _xstatistics & numerical data
650	0	4	_aEndothelial Growth Factors _xgenetics
650	0	4	_aGenetic Therapy
650	0	4	_aGenetic Vectors _xgenetics
650	0	4	_aHumans
650	0	4	_aLymphokines _xgenetics
650	0	4	_aRisk Assessment
650	0	4	_aRisk Factors
650	0	4	_aVascular Endothelial Growth Factor A
650	0	4	_aVascular Endothelial Growth Factors
700	1		_aVale, P R
700	1		_aSymes, J F
700	1		_aLosordo, D W
773	0		_tCirculation research _gvol. 89 _gno. 5 _gp. 389-400
856	4	0	_uhttps://doi.org/10.1161/hh1701.096259 _zAvailable from publisher's website
999			_c11456724 _d11456724